CLINICAL_TRIALS
trial_result
· 2009-08-25
Clinical Trial Update: A Randomised, Comparing Fixed Doses of Pramipexole to Investigate the Efficacy and Safety in Patients With RLS. [Phase 3]
Summary
A Phase 3 randomized trial evaluating fixed-dose Pramipexole for idiopathic restless legs syndrome; results were posted in 2009.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Idiopathic Restless Legs Syndrome | Phase 3 | Status: COMPLETED | Results posted: 2009-08-25